title: Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations.
abstract: A series of ghrelin receptor ligands based on the trisubstituted 1,2,4-triazole structure were synthesized and evaluated for their in vitro binding and biological activity. In this study, we explored the significance of the aminoisobutyryl (Aib) moiety, a common feature in numerous growth hormone secretagogues described in the literature. Potent agonist and antagonist ligands of the growth hormone secretagogue receptor type 1a (GHS-R1a) were obtained, i.e., compounds 41 (JMV2894) and 17 (JMV3031). The best compounds were evaluated for their in vivo activity on food intake, after sc injection in rodents. Among the tested compounds, few of them were able to stimulate food intake and some others, i.e., compounds 4 (JMV2959), 17, and 52 (JMV3021), acted as potent in vivo antagonist of hexarelin-stimulated food intake. These compounds did not stimulate growth hormone secretion in rats and furthermore did not antagonize growth hormone secretion induced by hexarelin, revealing that it is possible to modulate food intake without altering growth hormone secretion.
authors.affiliation: Institut des Biomolécules Max Mousseron, UMR 5247, CNRS, Université Montpellier I et Université Montpellier II, BP 14491, Faculté de Pharmacie, 15 Avenue Charles Flahault, 34093 Montpellier Cedex 5, France.
authors.forename: Aline
authors.initials: A
authors.lastname: Moulin
authors.forename: Luc
authors.initials: L
authors.lastname: Demange
authors.forename: Gilbert
authors.initials: G
authors.lastname: Bergé
authors.forename: Didier
authors.initials: D
authors.lastname: Gagne
authors.forename: Joanne
authors.initials: J
authors.lastname: Ryan
authors.forename: Delphine
authors.initials: D
authors.lastname: Mousseaux
authors.forename: Annie
authors.initials: A
authors.lastname: Heitz
authors.forename: Daniel
authors.initials: D
authors.lastname: Perrissoud
authors.forename: Vittorio
authors.initials: V
authors.lastname: Locatelli
authors.forename: Antonio
authors.initials: A
authors.lastname: Torsello
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Galleyrand
authors.forename: Jean-Alain
authors.initials: JA
authors.lastname: Fehrentz
authors.forename: Jean
authors.initials: J
authors.lastname: Martinez
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D006224:Cricetinae; D004435:Eating / Q000187:drug effects; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D008024:Ligands; D008297:Male; D009842:Oligopeptides / Q000494:pharmacology; D011869:Radioligand Assay; D051381:Rats; D017207:Rats, Sprague-Dawley; D054440:Receptors, Ghrelin / Q000819:agonists* / Q000037:antagonists & inhibitors*; D011994:Recombinant Proteins / Q000819:agonists / Q000037:antagonists & inhibitors; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D014230:Triazoles / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology
chemical_list: D008024:Ligands; D009842:Oligopeptides; D054440:Receptors, Ghrelin; D011994:Recombinant Proteins; D014230:Triazoles; C086184:hexarelin; D013006:Growth Hormone; D002118:Calcium